These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 2500030

  • 1. Galactose feeding causes glomerular hyperperfusion: prevention by aldose reductase inhibition.
    Bank N, Coco M, Aynedjian HS.
    Am J Physiol; 1989 Jun; 256(6 Pt 2):F994-9. PubMed ID: 2500030
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA, DeRubertis FR.
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [Abstract] [Full Text] [Related]

  • 5. Prevention of hemodynamic and vascular albumin filtration changes in diabetic rats by aldose reductase inhibitors.
    Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR.
    Diabetes; 1989 Oct; 38(10):1258-70. PubMed ID: 2507378
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
    Tilton RG, Pugliese G, LaRose LS, Faller AM, Chang K, Province MA, Williamson JR.
    J Diabet Complications; 1991 Oct; 5(4):230-7. PubMed ID: 1779018
    [Abstract] [Full Text] [Related]

  • 8. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N, Tsui J, Johnson M.
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M, Fukui H, Kuwabara T, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [Abstract] [Full Text] [Related]

  • 14. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E, Varagiannis E.
    Pharmacology; 1985 Feb; 31(2):88-96. PubMed ID: 3927328
    [Abstract] [Full Text] [Related]

  • 15. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening--prevention by an aldose reductase inhibitor.
    Das A, Frank RN, Zhang NL, Samadani E.
    Exp Eye Res; 1990 Mar; 50(3):269-80. PubMed ID: 2108050
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vascular filtration function in galactose-fed versus diabetic rats: the role of polyol pathway activity.
    Pugliese G, Tilton RG, Speedy A, Chang K, Province MA, Kilo C, Williamson JR.
    Metabolism; 1990 Jul; 39(7):690-7. PubMed ID: 2114513
    [Abstract] [Full Text] [Related]

  • 18. Time-dependent aspects of osmolyte changes in rat kidney, urine, blood and lens with sorbinil and galactose feeding.
    Edmands SD, Hughs KS, Lee SY, Meyer SD, Saari E, Yancey PH.
    Kidney Int; 1995 Aug; 48(2):344-53. PubMed ID: 7564101
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.